FL: Tafasitamab Plus Combo Boosts OutcomesDecember 18, 2024Non-Hodgkin LymphomaIndolent LymphomaB Cell LymphomaDLBCL
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Patient & Survivor CareMixed TopicsDLBCLBusiness of MedicineAggressive LymphomasAMLALL
POLARIX: Extended Results Confirm Standard of Care for DLBCLDecember 11, 2024DLBCLNon-Hodgkin LymphomaASH 2024
Epcore NHL-1 Update: Treatment Effective Before CAR TDecember 10, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaCellular TherapyASH 2024
High-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD OutcomesDecember 9, 2024TransplantPatient & Survivor CareALLCLLNon-Hodgkin LymphomaMyelodysplastic SyndromeMixed Topics
LBCL: Bispecific Antibodies Fare Less Well in Real-World AnalysisDecember 9, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaPatient & Survivor CareASH 2024
Inside the Patient-Oncologist Bond: Why It’s Often So StrongDecember 2, 2024Patient & Survivor CareMixed TopicsDLBCLMultiple MyelomaAMLAggressive LymphomasALL
Michigan Oncologist Charged in Scheme to Illegally Sell Cancer DrugsOctober 31, 2024Non-Hodgkin LymphomaBusiness of MedicineMixed TopicsT Cell Lymphomas
Lymphoma Debate: CAR T Not a Clear WinnerOctober 25, 2024Non-Hodgkin LymphomaGene TherapyCellular Therapy
Expert Updates Therapy for Waldenström MacroglobulinemiaOctober 25, 2024Non-Hodgkin LymphomaGene Therapy
For Radiation ‘Downwinders,’ Cancer Compensation Is On HoldOctober 25, 2024Patient & Survivor CareNon-Hodgkin LymphomaMultiple MyelomaDLBCLCMLALLAML
Popular Weight Loss Drugs Now for Patients With Cancer?September 30, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Does Medicare Advantage Offer Higher-Value Chemotherapy?September 26, 2024Patient & Survivor CareMixed TopicsBusiness of MedicineALLAggressive LymphomasAMLB Cell Lymphoma
AACR Cancer Progress Report: Big Strides and Big GapsSeptember 26, 2024Patient & Survivor CareDiversity in MedicineDLBCLMixed TopicsPediatricsAggressive LymphomasALL
Cancer Risk: Are Pesticides the New Smoking?September 20, 2024Patient & Survivor CareALLAMLAggressive LymphomasB Cell LymphomaBusiness of MedicineCLL
